InsidersTradesSigma
Follow the Relypsa Inc share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). The latest transaction was reported on 4 January 2016 (Levée d'options). Among the most active insiders: Stahl Wilhelm. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Relypsa Inc is a biopharmaceutical company focused on developing treatments for kidney diseases. It is listed on NASDAQ under the ticker RLYP.